Cite
HARVARD Citation
Sanchez, L. et al. (2020). Immunomodulatory drug- and proteasome inhibitor-backbone regimens in the treatment of relapsed multiple myeloma: an evidence-based review. Expert review of hematology. 13 (9), pp. 943-958. [Online].